UnitedHealthcare
Exkivity (mobocertinib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limits Apply
  • Prior Authorization: NSCLC EGFR Mutated:
    Documented Diagnosis: Yes
    Age Requirement: < 19
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • NSCLC EGFR Mutated:
    Age Requirement: < 19
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

  • Orally administered anticancer medication.